![Pierre Beaurang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre Beaurang
Directeur/Membre du Conseil chez
ORYZON GENOMICS S.A.
Profil
Pierre Beaurang currently works at Oryzon Genomics SA, as Independent Director from 2025.
Dr. Beaurang also formerly worked at Nitrase Therapeutics, Inc., as Chief Executive Officer & Director and Nurix Therapeutics, Inc., as Vice President-Business & Corporate Development from 2014 to 2016.
Dr. Beaurang received his undergraduate degree and graduate degree from Boston University and doctorate degree from the University of California, Berkeley.
Postes actifs de Pierre Beaurang
| Sociétés | Poste | Début |
|---|---|---|
| ORYZON GENOMICS S.A. | Directeur/Membre du Conseil | 28/02/2025 |
Anciens postes connus de Pierre Beaurang
| Sociétés | Poste | Fin |
|---|---|---|
Nitrase Therapeutics, Inc.
 Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel medicines for diseases | Directeur Général | - |
| NURIX THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Pierre Beaurang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oryzon Genomics SA
 Oryzon Genomics SA BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops epigenetics-based therapeutics | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nitrase Therapeutics, Inc.
Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel medicines for diseases | Commercial Services |
Choisissez Zonebourse 
